Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study

The disease caused by SARS-CoV-2 is still considered a global pandemic. Transdermal patches (TP) with immunoregulators such as estrogen and progesterone compounds could be a feasible option to treat COVID-19 because of their accessibility and relative safety. The objective of the current study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfredo, Cortés-Algara, Noemí, Cárdenas-Rodríguez, Samuel, Reyes-Long, Daniel, Ortega-Cuellar, Rodrigo, Ruz-Barros, Paul, Mondragón-Terán, Mónica, Escamilla-Tilch, José, Correa-Basurto, Eleazar, Lara-Padilla, Alfonso, Alfaro-Rodríguez, Luis, Cortes-Altamirano José, Cindy, Bandala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228088/
https://www.ncbi.nlm.nih.gov/pubmed/35745676
http://dx.doi.org/10.3390/ph15060757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228088/
https://www.ncbi.nlm.nih.gov/pubmed/35745676
http://dx.doi.org/10.3390/ph15060757

Ejemplares similares